In vitro oogenesis: How far have we come?

被引:0
|
作者
Arkoun, B. [1 ]
Livera, G. [1 ]
机构
[1] Univ Paris Saclay, Univ Paris Sud,Lab Dev Gonades,Inserm, Sorbonne Paris Cite,Unite Stabilite Genet Cellule, Univ Paris Diderot,CEA DRF iRCM SCSR,UMR 967, F-92265 Fontenay Aux Roses, France
来源
关键词
Oogenesis; ESC/iPSC; PGC-LC; In vitro; PRIMORDIAL GERM-CELLS; EMBRYONIC STEM-CELLS; SPECIFICATION; INDUCTION; CULTURE; OOCYTES; RECONSTITUTION; FATE; BMP4;
D O I
10.1016/j.gofs.2017.11.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Oogenesis is a complex cellular and molecular process whose fundamental mechanisms are still poorly described or not yet elucidated, especially in human species. The development of an in vitro model of oogenesis, particularly during fetal development in humans, is a critical step that would allow: (i) a better understand of the biological mechanisms of oogenesis; (ii) a refinement of medical diagnosis for women suffering from infertility; and (iii) providing new therapeutics for reproductive pathologies. The genesis of this model could be considered from ES/iPS cells. In this article, we will trace the physiological mechanisms of oogenesis in vivo and discuss the studies carried out in the field of in vitro oogenesis from ES/iPS cells, as well as the challenges to be met in the future. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 50 条
  • [21] Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
    Gajjela, Harini
    Kela, Iljena
    Kakarala, Chandra L.
    Hassan, Mohammad
    Belavadi, Rishab
    Gudigopuram, Sri Vallabh Reddy
    Raguthu, Ciri C.
    Modi, Srimy
    Sange, Ibrahim
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [22] Electronic health records: How far have we come? How far do we have to go?
    Waegemann, CP
    TOWARD AN ELECTRONIC HEALTH RECORD EUROPE '97 - CONFERENCE ON THE CREATION OF A EUROPEAN ELECTRONIC HEALTH RECORD, CONFERENCE PROCEEDINGS, 1997, : 8 - 10
  • [23] DIVERSITY AND INCLUSION: HOW FAR HAVE WE COME? HOW FAR CAN WE GO?
    Pennington, Greg
    CONSULTING PSYCHOLOGY JOURNAL-PRACTICE AND RESEARCH, 2020, 72 (04) : 324 - 331
  • [24] Tracheobronchomalacia treatment: how far have we come?
    Lopez-Padilla, Daniel
    Garcia-Lujan, Ricardo
    Puente Maestu, Luis
    de Miguel Poch, Eduardo
    JOURNAL OF THORACIC DISEASE, 2016, 8 (12) : 3490 - 3493
  • [25] Cardiopulmonary Resuscitation How Far Have We Come?
    Whitcomb, John J.
    Blackman, Virginia Schmied
    DIMENSIONS OF CRITICAL CARE NURSING, 2007, 26 (01) : 1 - 6
  • [26] Immunotherapy in myeloma: how far have we come?
    Franssen, Laurens E.
    Mutis, Tuna
    Lokhorst, Henk M.
    van de Donk, Niels W. C. J.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10 : 1 - 19
  • [27] Cardiac Retransplantation: How Far Have We Come?
    Pandya, K.
    Lyons, K.
    Nsair, A.
    Baas, A.
    Cadeiras, M.
    Cruz, D.
    Reardon, L.
    Deng, M.
    Ardehali, A.
    Depasquale, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S170 - S170
  • [28] Microbial proteomics: how far have we come?
    Cordwell, Stuart J.
    MICROBIOLOGY AUSTRALIA, 2011, 32 (04) : 169 - 173
  • [29] Chemical cordotomy ... how far have we come?
    Pawl, Ron
    SURGICAL NEUROLOGY, 2008, 70 (06): : 599 - 599
  • [30] The History of Biomarkers How Far Have We Come?
    Lachmann, Gunnar
    Reinhart, Konrad
    CRITICAL CARE CLINICS, 2020, 36 (01) : 1 - +